Eradication rate of Helicobacter pylori infection in Chinese duodenal ulcer patients treated with Vonoprazan 20 mg versus Lansoprazole 30 mg with bismuth containing quadruple therapy
单位：[1]China-Japan Union Hospital, Jilin University, Changchun, China吉林大学中日联谊医院[2]Huazhong University of Science and Technology, Wuhan, China[3]Beijing Friendship Hospital, Capital Medical University, Beijing, China首都医科大学附属北京友谊医院[4]Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangdong Geriatrics Institute, Guangdong, China广东省人民医院[5]Takeda Development Center Asia, Shanghai, China[6]Takeda Pharmaceutical Company, Osaka, Japan[7]Takeda Pharmaceutical Company, Beijing, China
第一作者单位：[1]China-Japan Union Hospital, Jilin University, Changchun, China
推荐引用方式(GB/T 7714)：
J. Wang,X. Hou,F. Meng,et al.Eradication rate of Helicobacter pylori infection in Chinese duodenal ulcer patients treated with Vonoprazan 20 mg versus Lansoprazole 30 mg with bismuth containing quadruple therapy[J].HELICOBACTER.2020,25:7-8.
APA：
J. Wang,X. Hou,F. Meng,W. Sha,L. Gu...&S. Zhang.(2020).Eradication rate of Helicobacter pylori infection in Chinese duodenal ulcer patients treated with Vonoprazan 20 mg versus Lansoprazole 30 mg with bismuth containing quadruple therapy.HELICOBACTER,25,
MLA：
J. Wang,et al."Eradication rate of Helicobacter pylori infection in Chinese duodenal ulcer patients treated with Vonoprazan 20 mg versus Lansoprazole 30 mg with bismuth containing quadruple therapy".HELICOBACTER 25.(2020):7-8
